{"id":61615,"date":"2025-06-19T08:33:29","date_gmt":"2025-06-19T14:33:29","guid":{"rendered":"https:\/\/themexicopost.com\/?p=61615"},"modified":"2025-06-26T05:29:20","modified_gmt":"2025-06-26T11:29:20","slug":"aprueba-fda-inyeccion-contra-vih-con-solo-dos-dosis-al-ano","status":"publish","type":"post","link":"https:\/\/themexicopost.com\/?p=61615","title":{"rendered":"APRUEBA FDA INYECCI\u00d3N CONTRA VIH CON SOLO DOS DOSIS AL A\u00d1O"},"content":{"rendered":"\n<figure class=\"wp-block-pullquote\"><blockquote><p>Se\u00f1alan que el estudio PURPOSE 1, mostr\u00f3 m\u00e1s del 99% de eficacia en mujeres j\u00f3venes en \u00c1frica subsahariana.<\/p><\/blockquote><\/figure>\n\n\n\n<p class=\"has-drop-cap wp-block-paragraph\">La empresa biofarmac\u00e9utica Gilead Sciences anunci\u00f3 que la FDA (Food and Drug Administration) aprob\u00f3 \u201cYeztugo\u201d (lenacapavir), el primer y \u00fanico tratamiento profil\u00e1ctico contra el VIH que se administra solo dos veces al a\u00f1o, ofreciendo seis meses de protecci\u00f3n continua.<br><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">El respaldo de la FDA se bas\u00f3 en los resultados del estudio PURPOSE 1, donde el f\u00e1rmaco, denominado \u201cYeztugo\u201d, demostr\u00f3 una eficacia superior al 99\u202f% en la prevenci\u00f3n de infecciones entre mujeres j\u00f3venes en \u00c1frica subsahariana, una de las poblaciones m\u00e1s vulnerables.<br><\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img fetchpriority=\"high\" decoding=\"async\" width=\"1024\" height=\"684\" src=\"https:\/\/themexicopost.com\/wp-content\/uploads\/2025\/06\/aprueba-3-1024x684.jpg\" alt=\"\" class=\"wp-image-61617\" srcset=\"https:\/\/themexicopost.com\/wp-content\/uploads\/2025\/06\/aprueba-3-1024x684.jpg 1024w, https:\/\/themexicopost.com\/wp-content\/uploads\/2025\/06\/aprueba-3-300x201.jpg 300w, https:\/\/themexicopost.com\/wp-content\/uploads\/2025\/06\/aprueba-3-768x513.jpg 768w, https:\/\/themexicopost.com\/wp-content\/uploads\/2025\/06\/aprueba-3.jpg 1200w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">El CEO de Gilead, Daniel O\u00b4Day, declar\u00f3 que este es un d\u00eda hist\u00f3rico en la larga lucha contra el VIH. Yeztugo podr\u00eda transformar la prevenci\u00f3n y acercarnos a acabar con esta epidemia.<br><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">El tratamiento se administra como dos inyecciones subcut\u00e1neas en el abdomen, que forman un dep\u00f3sito liberado lentamente durante seis meses.<br><\/p>\n\n\n\n<figure class=\"wp-block-image size-large\"><img decoding=\"async\" width=\"1024\" height=\"684\" src=\"https:\/\/themexicopost.com\/wp-content\/uploads\/2025\/06\/aprueba-1024x684.jpg\" alt=\"\" class=\"wp-image-61618\" srcset=\"https:\/\/themexicopost.com\/wp-content\/uploads\/2025\/06\/aprueba-1024x684.jpg 1024w, https:\/\/themexicopost.com\/wp-content\/uploads\/2025\/06\/aprueba-300x201.jpg 300w, https:\/\/themexicopost.com\/wp-content\/uploads\/2025\/06\/aprueba-768x513.jpg 768w, https:\/\/themexicopost.com\/wp-content\/uploads\/2025\/06\/aprueba.jpg 1200w\" sizes=\"(max-width: 1024px) 100vw, 1024px\" \/><\/figure>\n\n\n\n<p class=\"wp-block-paragraph\">Se requieren pruebas de VIH negativas antes de cada dosis. Gilead estableci\u00f3 el precio en Estados Unidos en 28,218 d\u00f3lares anuales, anticipando que la mayor\u00eda de los seguros cubrir\u00e1n el tratamiento; tambi\u00e9n ofrece programas de asistencia financiera.<br><\/p>\n\n\n\n<p class=\"wp-block-paragraph\">A nivel global, Gilead firm\u00f3 licencias sin regal\u00edas con seis fabricantes gen\u00e9ricos, para cubrir 120 pa\u00edses de ingresos bajos, con un compromiso de distribuir dosis gratuitas a dos millones de personas durante los pr\u00f3ximos a\u00f1os.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Se\u00f1alan que el estudio PURPOSE 1, mostr\u00f3 m\u00e1s del 99% de eficacia en mujeres j\u00f3venes en \u00c1frica subsahariana.<\/p>\n","protected":false},"author":1,"featured_media":61616,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[83,80,85],"tags":[],"class_list":["post-61615","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-destacado","category-mundo","category-portada"],"_links":{"self":[{"href":"https:\/\/themexicopost.com\/index.php?rest_route=\/wp\/v2\/posts\/61615","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/themexicopost.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/themexicopost.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/themexicopost.com\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/themexicopost.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=61615"}],"version-history":[{"count":1,"href":"https:\/\/themexicopost.com\/index.php?rest_route=\/wp\/v2\/posts\/61615\/revisions"}],"predecessor-version":[{"id":61619,"href":"https:\/\/themexicopost.com\/index.php?rest_route=\/wp\/v2\/posts\/61615\/revisions\/61619"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/themexicopost.com\/index.php?rest_route=\/wp\/v2\/media\/61616"}],"wp:attachment":[{"href":"https:\/\/themexicopost.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=61615"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/themexicopost.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=61615"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/themexicopost.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=61615"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}